Esophageal regenerative therapy using cell sheet technology.
Regen Ther
; 13: 8-17, 2020 Mar.
Article
in En
| MEDLINE
| ID: mdl-33490318
We have been conducting research on esophageal regenerative therapy using cell sheet technology. In particular, in the endoscopic field, we have pushed forward clinical research on endoscopic transplantation of cultured autologous oral mucosal epithelial cell sheets to esophageal ulcer after endoscopic submucosal dissection (ESD). We started research in this direction using animal models in 2004 and performed clinical research in 2012 in collaboration with Nagasaki University and Karolinska Institute. Although in full-circumferential cases it was difficult to prevent esophageal stricture after ESD, there were no complications and stricture could be suppressed. The cell sheet technology is still in its infancy. However, we are convinced that it has a high potential for application in various areas of gastrointestinal science. In this review, we focus on the pre-clinical and clinical trial results obtained and on the theoretical aspects of (1) stricture prevention, (2) esophageal tissue engineering research, and (3) endoscopic transplantation, and review the esophageal regenerative therapy by cell sheet technology.
CMC, carboxymethyl cellulose; CPC, cell-processing center; Cell sheet technology; EBD, endoscopic balloon dilation; ECM, extracellular matrix; EMR, endoscopic mucosal dissection; ESD, endoscopic submucosal dissection; Endoscopic submucosal dissection (ESD); Endoscopic transplantation; Esophageal stricture; GMP, good manufacturing practice; OMECS, oral mucosal epithelial cell sheet; PGA, polyglycolic acid; PIPAAm, poly(N-isopropylacrylamide); PVDF, polyvinylidene difluoride; Regenerative medicine; SEMS, self-expandable metallic stent; TAC, triamcinolone; Tissue-engineered oral mucosal
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Regen Ther
Year:
2020
Document type:
Article
Affiliation country:
Japan
Country of publication:
Netherlands